SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-029427
Filing Date
2020-06-16
Accepted
2020-06-16 07:10:26
Documents
15
Period of Report
2020-06-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nbix-8k_20200612.htm   iXBRL 8-K 66008
2 EX-99.1 nbix-ex991_17.htm EX-99.1 32610
3 GRAPHIC gcjj3cauwzyv000001.jpg GRAPHIC 3367
4 GRAPHIC gcjj3cauwzyv000002.jpg GRAPHIC 2608
  Complete submission text file 0001564590-20-029427.txt   246707

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA nbix-20200612.xsd EX-101.SCH 5784
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE nbix-20200612_lab.xml EX-101.LAB 18732
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nbix-20200612_pre.xml EX-101.PRE 11179
8 EXTRACTED XBRL INSTANCE DOCUMENT nbix-8k_20200612_htm.xml XML 3416
Mailing Address 12780 EL CAMINO REAL SAN DIEGO CA 92130
Business Address 12780 EL CAMINO REAL SAN DIEGO CA 92130 (858) 617-7600
NEUROCRINE BIOSCIENCES INC (Filer) CIK: 0000914475 (see all company filings)

IRS No.: 330525145 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22705 | Film No.: 20964966
SIC: 2836 Biological Products, (No Diagnostic Substances)